The Impact of Data Analytics on Centralized Distribution Center Operations in the Pharmaceutical Industry
DOI:
https://doi.org/10.47941/ijce.2923Keywords:
Pharmaceutical Distribution Centralization, Data Analytics, Supply Chain Optimization, Inventory Visibility, Regulatory ComplianceAbstract
Purpose: This article examines the transformative impact of data analytics on pharmaceutical distribution centre operations through centralization initiatives. The study investigates how analytics-driven centralization simultaneously addresses the seemingly competing objectives of cost reduction and service improvement in pharmaceutical distribution networks, exploring the multifaceted benefits across economic, operational, and strategic dimensions.
Methodology: The research employs a mixed-methods approach combining quantitative operational data analysis from five pharmaceutical distribution networks representing 37 distribution centres over a 24-month period with qualitative insights from 28 industry practitioners. The study captures both pre- and post-centralization performance metrics, utilizing difference-in-differences analysis, time series modelling, and multivariate regression to isolate the causal impact of centralization initiatives.
Findings: Centralized distribution operations yield substantial improvements including 14.7% reduction in operating costs, fill rate increases from 91.3% to 96.7%, 31% improvement in demand forecasting accuracy, and 73% reduction in compliance-related incidents. The research reveals that real-time visibility enables 94% faster decision-making, more efficient stock imbalance detection, and enhanced responsiveness to supply chain disruptions. Beyond operational benefits, centralization creates strategic advantages including improved customer satisfaction, competitive differentiation, and organizational agility.
Unique Contribution to Theory, Policy and Practice: This study addresses a significant gap in the literature by integrating technological, operational, and organizational perspectives on pharmaceutical distribution centralization. It provides the first comprehensive framework demonstrating how analytics-driven centralization can simultaneously optimize cost efficiency and service levels in highly regulated environments. The research offers practitioners actionable implementation strategies and mitigation approaches for common challenges, while contributing to supply chain theory by establishing the synergistic relationship between network-level analytics and operational performance in pharmaceutical distribution contexts.
Downloads
References
Angie Nguyen, Samir Lamouri et al. “Advanced Analytics in Pharmaceutical Supply Chains: A Systematic Review of Benefits and Implementation Challenges”. Journal of Pharmaceutical Distribution, 45(3), 287-302, 19 Jul 2021. https://www.tandfonline.com/doi/full/10.1080/00207543.2021.1950937
Dan Walles, SCB Contributor. “The State of End-to-End Digital Supply Chain Networks in Pharma and Life Sciences”. SupplyChainBrain, April 7, 2025. https://www.supplychainbrain.com/blogs/1-think-tank/post/41400-the-state-of-end-to-end-digital-supply-chain-networks-in-pharma-and-life-sciences
matellio. “Prescriptive Analytics in Healthcare – How It Can Transform Your Organization”. October 23, 2024. https://www.matellio.com/blog/prescriptive-analytics-in-healthcare/
Vimal Kumar Dixit, Rakesh Kumar Malviya, et al. "An Analysis of the Strategies for Overcoming Digital Supply Chain Implementation Barriers." Decision Analytics Journal 10, (March 2024): 100389. https://www.sciencedirect.com/science/article/pii/S2772662223002291
Victor Alemede et al. “Data-driven strategies for optimizing pharmaceutical supply chains in the United States: A framework for entrepreneurial excellence”. 23 October 2022 . https://magnascientiapub.com/journals/msarr/sites/default/files/MSARR-2022-0067.pdf
Ampong Afoakwah Emmanuel et al. “Real-Time Supply Chain Management Visibility: Aspirations and Opportunities”. Current Science. 12. 13, November 2022. https://www.researchgate.net/publication/365429962_Real-Time_Supply_Chain_Management_Visibility_Aspirations_and_Opportunities
Dina Al Nuaimi, Niyi Awofeso. “The Value of Applying Big Data Analytics in Health Supply Chain Management”. F1000Res. 2025 Feb 19;13:1237. doi: 10.12688/f1000research.156525.4. PMID: 39989480; PMCID: PMC11842960. https://pmc.ncbi.nlm.nih.gov/articles/PMC11842960/
Compliancequest.“Regulatory Compliance for Pharmaceutical Industry: A Comprehensive Guide for 2025”. https://www.compliancequest.com/bloglet/regulatory-compliance-for-pharmaceutical-industry/
V. M. Rao Tummala, et al. “Assessing supply chain management success factors: A case study”. Supply Chain Manage. 1 March 2006.179-192. 10.1108/13598540610652573. https://www.emerald.com/insight/content/doi/10.1108/13598540610652573/full/html
Abhijeet Ghadge,Michael Bourlakis et al. “Blockchain implementation in pharmaceutical supply chains: A review and conceptual framework”. International Journal of Production Research. 61. 10.1080/00207543.2022.2125595. 05 Oct 2022. https://www.tandfonline.com/doi/full/10.1080/00207543.2022.2125595
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Vishal Kumar Sharma

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.